Furthermore, due to the technological limitations, we did not promulgate any direct target genes of MKK7 with respect to the p.Glu116Lys rare polymorphism, which might help us to understand the precisely molecular mechanism of this rare SNP on influencing cancer risk and progression. This evidence concerns the gene MAP2K7 and cancer.